Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T lymphocyte (T cell) activation is a fundamental process in the adaptive immune response, enabling T cells to recognize and respond to specific antigens. This process is tightly regulated and involves multiple molecular interactions and signaling pathways that ensure precise immune responses against pathogens while minimizing autoimmunity. The classical model of T cell activation requires antigen recognition (Signal 1), co-stimulation (Signal 2), and cytokine signaling (Signal 3), leading to clonal expansion, differentiation into effector/memory subsets, and effector function development. Dysregulation can lead to immunodeficiency or autoimmunity, making key steps in this pathway therapeutic targets for autoimmune diseases, cancer, and infectious diseases.
Modulation of T cell receptor signaling, co-stimulation, or cytokine signaling to either suppress or enhance T cell activity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T Lymphocyte Activation (T cell activation).